# How N-Acylethanolamines Control Appetite, Energy Balance, and Metabolic Health > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/n-acylethanolamines-appetite-regulation-metabolic-health/ > **Published:** 2026-03-13T11:27:09-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:08:09-04:00 > **Clinical Summary:** Explore how n-acylethanolamines appetite regulation impacts energy balance and metabolic health, offering insights into cannabis effects on metabolism. --- ✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchNeurologyMetabolism Why This Matters Understanding how N-acylethanolamines regulate appetite and metabolic pathways provides clinicians with mechanistic insights into cannabis effects on weight, [glucose metabolism](https://cedclinic.com/tetrahydrocannabinol-brain-glucose-consumption-metabolic-modulation/), and energy homeostasis that influence treatment decisions for patients with obesity, diabetes, or metabolic syndrome. This knowledge helps clinicians counsel patients on cannabis use’s metabolic consequences and identify which cannabinoid compounds might have therapeutic potential versus those causing metabolic harm. Given the widespread use of cannabis for [appetite stimulation](https://cedclinic.com/dronabinol-hiv-wasting-syndrome-appetite-weight-gain/), understanding these receptor pathways enables evidence-based prescribing guidance and patient monitoring for metabolic complications. Clinical Summary This article examines N-acylethanolamines (NAEs), a class of lipid signaling molecules that includes endocannabinoids and related compounds, and their role in regulating appetite, energy expenditure, and metabolic homeostasis through [cannabinoid receptors](https://cedclinic.com/citral-cannabinoid-receptor-2-activation-pain-relief/), nuclear receptors, and G-protein-coupled receptor pathways. Understanding the pharmacology of endogenous NAEs provides mechanistic insight into how cannabis and cannabinoid-based therapeutics influence metabolic processes, potentially explaining both therapeutic benefits and adverse metabolic effects observed in [clinical cannabis](https://cedclinic.com/entourage-effect-cannabis-clinical-breeding-benefits/) users. The research highlights that NAE signaling represents a complex, multi-receptor system that extends beyond simple CB1 and CB2 activation, suggesting that future cannabis-derived therapeutics could be more precisely targeted to metabolic indications while minimizing off-target effects. For clinicians, this foundational knowledge is relevant when counseling patients about cannabis use and metabolic side effects such as weight gain or altered appetite, and when considering cannabinoid-based treatments for conditions like cachexia or metabolic disorders. Clinicians should recognize that individual variation in NAE metabolism and receptor expression may explain variable metabolic responses to cannabis among patients, supporting the need for personalized counseling and monitoring. Dr. Caplan’s Take “What we’re learning about N-acylethanolamines fundamentally changes how we think about cannabis’s metabolic effects, because these endogenous compounds work through multiple receptor systems beyond CB1 and CB2, which means a patient’s response to cannabis depends on their own lipid signaling capacity, not just the cannabinoid content they’re consuming.” Clinical Perspective N-acylethanolamines (NAEs), a lipid class encompassing endocannabinoids and related compounds, represent a promising but still poorly characterized system for regulating appetite and energy homeostasis through cannabinoid and non-cannabinoid receptor pathways. The distinction between endogenous NAE signaling and exogenous cannabis effects is clinically important, as these may operate through overlapping but distinct mechanisms, and current evidence in humans remains limited compared to preclinical models. Clinicians should recognize that patients using cannabis for [appetite stimulation](https://cedclinic.com/dronabinol-hiv-wasting-syndrome-appetite-weight-gain/) or weight management may experience effects mediated by multiple receptor systems beyond CB1 and CB2, potentially explaining variable individual responses and side effect profiles. The complexity of NAE biology also suggests that future cannabis-based therapeutics targeting metabolism may require greater specificity than whole-plant or broad-spectrum products currently available. Until human pharmacodynamic studies clarify how cannabis consumption alters 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-related-research/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+How+N-Acylethanolamines+Control+Appetite%2C+Energy+Balance%2C+and+Metabolic+Health+%40drcaplan&url=https%3A%2F%2Fwww.news-medical.net%2Fhealth%2FHow-N-Acylethanolamines-Control-Appetite-Energy-Balance-and-Metabolic-Health.aspx)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.news-medical.net%2Fhealth%2FHow-N-Acylethanolamines-Control-Appetite-Energy-Balance-and-Metabolic-Health.aspx)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+How+N-Acylethanolamines+Control+Appetite%2C+Energy+Balance%2C+and+Metabolic+Health+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fwww.news-medical.net%2Fhealth%2FHow-N-Acylethanolamines-Control-Appetite-Energy-Balance-and-Metabolic-Health.aspx)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.news-medical.net/health/How-N-Acylethanolamines-Control-Appetite-Energy-Balance-and-Metabolic-Health.aspx](https://www.news-medical.net/health/How-N-Acylethanolamines-Control-Appetite-Energy-Balance-and-Metabolic-Health.aspx) Further Reading Evidence Watch[The Brain Science Behind the Munchies – Nautilus Magazine](https://cedclinic.com/cannabis-appetite-stimulation-neuroscience/) Evidence WatchIGC Pharma Adds Visionary Investigators Network as Clinical Site to Phase 2 CALMA Trial Research Digest[AM Policy Update: March 11, 2026](https://cedclinic.com/dea-rescheduling-marijuana-march-11-2026/) Nationwide GLP-1 Care Looking for thoughtful, physician-led GLP-1 guidance? CED Clinic offers GLP-1 and metabolic guidance across the United States, including evaluation, prescribing support, side-effect management, and longer-term follow-up for people seeking careful, personalized care. [Learn More](https://cedclinic.com/metabolic/) [Book Now](https://book.squareup.com/appointments/kn3vehwoiz6to6/location/DPV0VF8Y74WA7/services) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Why some people may feel hungry after smoking weed – K24 Digital](https://cedclinic.com/why-some-people-may-feel-hungry-after-smoking-weed-k24-digital/) Explore the reasons behind increased hunger after cannabis use and its relation to appetite regulation. [Read More](https://cedclinic.com/why-some-people-may-feel-hungry-after-smoking-weed-k24-digital/) [Natural Neuroprotection: Exploring the Potential of Non-Psychoactive Cannabinoids](https://cedclinic.com/non-psychoactive-cannabinoids-neuroprotection-potential/) Learn about non-psychoactive cannabinoids and their potential benefits for [brain health and metabolism](https://cedclinic.com/reverse-cholesterol-transport-function-cannabis-users/). [Discover More](https://cedclinic.com/non-psychoactive-cannabinoids-neuroprotection-potential/) [Munchies phenomenon: WSU study looks into benefits of cannabis use and hunger – KIRO 7](https://cedclinic.com/thc-triggers-appetite-brain-cannabis-hunger-study/) Study findings on how cannabis influences hunger and appetite, relevant to metabolic health discussions. [Learn More](https://cedclinic.com/thc-triggers-appetite-brain-cannabis-hunger-study/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).